Mostrar el registro sencillo

dc.contributor.authorTort Merino, Adrià
dc.contributor.authorPérez Millan, Agnès
dc.contributor.authorFalgàs, Neus
dc.contributor.authorBorrego Écija, Sergi
dc.contributor.authorEsteller, Diana
dc.contributor.authorBosch, Bea
dc.contributor.authorCastellví, Magdalena
dc.contributor.authorJuncà Parella, Jordi
dc.contributor.authordel Val Guardiola, Andrea
dc.contributor.authorFernández Villullas, Guadalupe
dc.contributor.authorAntonell, Anna
dc.contributor.authorSanchez Saudinós, María Belén
dc.contributor.authorRubio Guerra, Sara
dc.contributor.authorZhu, Nuole
dc.contributor.authorGarcía Martínez, María
dc.contributor.authorPozueta Cantudo, Ana
dc.contributor.authorEstanga, Ainara
dc.contributor.authorEcay Torres, Mirian
dc.contributor.authorRodríguez Rodríguez, Eloy Manuel 
dc.contributor.authorLópez de Luis, Carolina
dc.contributor.otherUniversidad de Cantabriaes_ES
dc.date.accessioned2025-07-14T08:56:14Z
dc.date.available2025-07-14T08:56:14Z
dc.date.issued2025
dc.identifier.issn1552-5260
dc.identifier.issn1552-5279
dc.identifier.otherAACSF-21-850193
dc.identifier.urihttps://hdl.handle.net/10902/36688
dc.description.abstractIntroduction: We aimed to determine whether cognitively unimpaired (CU) amyloid- beta-positive (A+) individuals display decreased practice effects on serial neuropsychological testing. Methods: We included 209 CU participants from three research centers, 157 A- controls and 52 A+ individuals. Participants underwent neuropsychological assessment at baseline and annually during a 2-year follow-up. We used linear mixed-effects models to analyze cognitive change over time between the two groups, including time from baseline, amyloid status, their interaction, age, sex, and years of education as fixed effects and the intercept and time as random effects. Results: The A+ group showed reduced practice effects in verbal learning (= -1.14, SE = 0.40, p = 0.0046) and memory function ( = -0.56, SE = 0.19, p = 0.0035), as well as in language tasks ( = -0.59, SE = 0.19, p = 0.0027). Discussion: Individuals with normal cognition who are in the Alzheimer's continuum show decreased practice effects over annual neuropsychological testing. Our findings could have implications for the design and interpretation of primary prevention trials. Highlights: This was a multicenter study on practice effects in asymptomatic A+ individuals. We used LME models to analyze cognitive trajectories across multiple domains. Practice-effects reductions might be an indicator of subtle cognitive decline. Implications on clinical and research settings within the AD field are discussed.es_ES
dc.description.sponsorshipThis work has been supported by the project PI19/00745 to LR, funded by Instituto de Salud Carlos III (ISCIII) and co-funded by the European Union. NF was recipient of Juan Rodés contract JR22/00014 (ISCIII). II-G is a senior Atlantic Fellow for Equity in Brain Health at the Global Brain Health Institute (GBHI) and receives funding from the GBHI, the Alzheimer’s Association, and the Alzheimer’s Society (GBHI ALZ UK-21-720973 and AACSF-21-850193). II-G was also supported by the Juan Rodés Contract (JR20/0018) and Instituto de Salud Carlos III (PI21/00791, PI24/00598). This work was supported by the Alzheimer’s Association Clinician Scientist Fellowship Program AACSF-21-850193 awarded to II-G. The GAP study was supported by Fundación CITA-Alzhéimer Fundazioa, the Ministry of Health of Spain (grants PI12/02262 and PI1500919), and the Basque Country Government (grants S-PR12CH001 and S-PR13ZH001).es_ES
dc.format.extent12 p.es_ES
dc.language.isoenges_ES
dc.publisherWileyes_ES
dc.rights© 2025 The Author(s). Alzheimer’s & Dementia published by Wiley Periodicals LLC on behalf of Alzheimer’s Association. This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.es_ES
dc.rights.urihttp://creativecommons.org/licenses/by-nc/4.0/.*
dc.sourceAlzheimer's & Dementia: the Journal of the Alzheimer's Association, 2025, 21(3), e70016es_ES
dc.subject.otherAlzheimer’s diseasees_ES
dc.subject.otherCognitiones_ES
dc.subject.otherEarly detectiones_ES
dc.subject.otherNeuropsychological assessmentes_ES
dc.subject.otherPractice effectses_ES
dc.subject.otherSubtle cognitive declinees_ES
dc.titleDecreased practice effects in cognitively unimpaired amyloid betapositive individuals: a multicenter, longitudinal, cohort studyes_ES
dc.typeinfo:eu-repo/semantics/articlees_ES
dc.relation.publisherVersionhttps://doi.org/10.1002/alz.70016es_ES
dc.rights.accessRightsopenAccesses_ES
dc.identifier.DOI10.1002/alz.70016
dc.type.versionpublishedVersiones_ES


Ficheros en el ítem

Thumbnail

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo

© 2025 The Author(s). Alzheimer’s & Dementia published by Wiley Periodicals LLC on behalf of Alzheimer’s Association. This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.Excepto si se señala otra cosa, la licencia del ítem se describe como © 2025 The Author(s). Alzheimer’s & Dementia published by Wiley Periodicals LLC on behalf of Alzheimer’s Association. This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.